Consumption of Meat, Fish, Dairy Products, and Eggs and Risk of Ischemic Heart Disease.
Adult
Aged
Biomarkers
/ blood
Blood Pressure
Cholesterol, HDL
/ blood
Cross-Sectional Studies
Dairy Products
/ adverse effects
Diet Surveys
Diet, Healthy
Eggs
/ adverse effects
Europe
/ epidemiology
Female
Humans
Male
Meat
/ adverse effects
Middle Aged
Myocardial Ischemia
/ blood
Nutritive Value
Prospective Studies
Protective Factors
Recommended Dietary Allowances
Risk Assessment
Risk Factors
Risk Reduction Behavior
Seafood
/ adverse effects
Time Factors
dairy products
eggs
fish
heart diseases
meat
Journal
Circulation
ISSN: 1524-4539
Titre abrégé: Circulation
Pays: United States
ID NLM: 0147763
Informations de publication
Date de publication:
18 06 2019
18 06 2019
Historique:
pubmed:
23
4
2019
medline:
24
3
2020
entrez:
23
4
2019
Statut:
ppublish
Résumé
There is uncertainty about the relevance of animal foods to the pathogenesis of ischemic heart disease (IHD). We examined meat, fish, dairy products, and eggs and risk for IHD in the pan-European EPIC cohort (European Prospective Investigation Into Cancer and Nutrition). In this prospective study of 409 885 men and women in 9 European countries, diet was assessed with validated questionnaires and calibrated with 24-hour recalls. Lipids and blood pressure were measured in a subsample. During a mean of 12.6 years of follow-up, 7198 participants had a myocardial infarction or died of IHD. The relationships of animal foods with risk were examined with Cox regression with adjustment for other animal foods and relevant covariates. The hazard ratio (HR) for IHD was 1.19 (95% CI, 1.06-1.33) for a 100-g/d increment in intake of red and processed meat, and this remained significant after exclusion of the first 4 years of follow-up (HR, 1.25 [95% CI, 1.09-1.42]). Risk was inversely associated with intakes of yogurt (HR, 0.93 [95% CI, 0.89-0.98] per 100-g/d increment), cheese (HR, 0.92 [95% CI, 0.86-0.98] per 30-g/d increment), and eggs (HR, 0.93 [95% CI, 0.88-0.99] per 20-g/d increment); the associations with yogurt and eggs were attenuated and nonsignificant after exclusion of the first 4 years of follow-up. Risk was not significantly associated with intakes of poultry, fish, or milk. In analyses modeling dietary substitutions, replacement of 100 kcal/d from red and processed meat with 100 kcal/d from fatty fish, yogurt, cheese, or eggs was associated with ≈20% lower risk of IHD. Consumption of red and processed meat was positively associated with serum non-high-density lipoprotein cholesterol concentration and systolic blood pressure, and consumption of cheese was inversely associated with serum non-high-density lipoprotein cholesterol. Risk for IHD was positively associated with consumption of red and processed meat and inversely associated with consumption of yogurt, cheese, and eggs, although the associations with yogurt and eggs may be influenced by reverse causation bias. It is not clear whether the associations with red and processed meat and cheese reflect causality, but they were consistent with the associations of these foods with plasma non-high-density lipoprotein cholesterol and for red and processed meat with systolic blood pressure, which could mediate such effects.
Sections du résumé
BACKGROUND
There is uncertainty about the relevance of animal foods to the pathogenesis of ischemic heart disease (IHD). We examined meat, fish, dairy products, and eggs and risk for IHD in the pan-European EPIC cohort (European Prospective Investigation Into Cancer and Nutrition).
METHODS
In this prospective study of 409 885 men and women in 9 European countries, diet was assessed with validated questionnaires and calibrated with 24-hour recalls. Lipids and blood pressure were measured in a subsample. During a mean of 12.6 years of follow-up, 7198 participants had a myocardial infarction or died of IHD. The relationships of animal foods with risk were examined with Cox regression with adjustment for other animal foods and relevant covariates.
RESULTS
The hazard ratio (HR) for IHD was 1.19 (95% CI, 1.06-1.33) for a 100-g/d increment in intake of red and processed meat, and this remained significant after exclusion of the first 4 years of follow-up (HR, 1.25 [95% CI, 1.09-1.42]). Risk was inversely associated with intakes of yogurt (HR, 0.93 [95% CI, 0.89-0.98] per 100-g/d increment), cheese (HR, 0.92 [95% CI, 0.86-0.98] per 30-g/d increment), and eggs (HR, 0.93 [95% CI, 0.88-0.99] per 20-g/d increment); the associations with yogurt and eggs were attenuated and nonsignificant after exclusion of the first 4 years of follow-up. Risk was not significantly associated with intakes of poultry, fish, or milk. In analyses modeling dietary substitutions, replacement of 100 kcal/d from red and processed meat with 100 kcal/d from fatty fish, yogurt, cheese, or eggs was associated with ≈20% lower risk of IHD. Consumption of red and processed meat was positively associated with serum non-high-density lipoprotein cholesterol concentration and systolic blood pressure, and consumption of cheese was inversely associated with serum non-high-density lipoprotein cholesterol.
CONCLUSIONS
Risk for IHD was positively associated with consumption of red and processed meat and inversely associated with consumption of yogurt, cheese, and eggs, although the associations with yogurt and eggs may be influenced by reverse causation bias. It is not clear whether the associations with red and processed meat and cheese reflect causality, but they were consistent with the associations of these foods with plasma non-high-density lipoprotein cholesterol and for red and processed meat with systolic blood pressure, which could mediate such effects.
Identifiants
pubmed: 31006335
doi: 10.1161/CIRCULATIONAHA.118.038813
pmc: PMC6629175
doi:
Substances chimiques
Biomarkers
0
Cholesterol, HDL
0
Types de publication
Journal Article
Multicenter Study
Observational Study
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
2835-2845Subventions
Organisme : Medical Research Council
ID : MR/L003120/1
Pays : United Kingdom
Organisme : Cancer Research UK
ID : C8221/A19170
Pays : United Kingdom
Organisme : Medical Research Council
ID : G0700463
Pays : United Kingdom
Organisme : British Heart Foundation
ID : RG/13/13/30194
Pays : United Kingdom
Organisme : Medical Research Council
ID : MC_UU_12015/1
Pays : United Kingdom
Organisme : Wellcome Trust
ID : 205212/Z/16/Z
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/N003284/1
Pays : United Kingdom
Organisme : Medical Research Council
ID : 1000143
Pays : United Kingdom
Organisme : Cancer Research UK
ID : 570/A16491
Pays : United Kingdom
Organisme : Medical Research Council
ID : G0401527
Pays : United Kingdom
Organisme : Medical Research Council
ID : G1000143
Pays : United Kingdom
Organisme : Cancer Research UK
ID : 25004
Pays : United Kingdom
Organisme : British Heart Foundation
ID : RG/18/13/33946
Pays : United Kingdom
Organisme : British Heart Foundation
ID : RG/08/014
Pays : United Kingdom
Organisme : Cancer Research UK
ID : 14136
Pays : United Kingdom
Organisme : Department of Health
ID : IS-BRC-1215-20014
Pays : United Kingdom
Organisme : Medical Research Council
ID : MC_UU_12015/5
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/M012190/1
Pays : United Kingdom
Organisme : British Heart Foundation
ID : SP/09/002
Pays : United Kingdom
Organisme : Medical Research Council
ID : G0800270
Pays : United Kingdom
Références
Blood Press Monit. 2002 Apr;7(2):95-104
pubmed: 12048426
Lancet. 2002 Dec 14;360(9349):1903-13
pubmed: 12493255
Public Health Nutr. 2002 Dec;5(6B):1113-24
pubmed: 12639222
Public Health Nutr. 2002 Dec;5(6B):1125-45
pubmed: 12639223
Eur J Epidemiol. 2007;22(2):129-41
pubmed: 17295097
Lancet. 2007 Dec 1;370(9602):1829-39
pubmed: 18061058
Int J Epidemiol. 2008 Apr;37(2):368-78
pubmed: 18180242
Br J Nutr. 2009 Nov;102(9):1267-75
pubmed: 19682399
JAMA. 2009 Nov 11;302(18):1993-2000
pubmed: 19903920
Am J Clin Nutr. 2011 Jan;93(1):158-71
pubmed: 21068345
Br J Nutr. 2011 Jun 28;105(12):1823-31
pubmed: 21281532
Public Health Nutr. 2012 Apr;15(4):725-37
pubmed: 21914258
Eur J Epidemiol. 2012 Jan;27(1):15-25
pubmed: 22089423
Curr Atheroscler Rep. 2012 Dec;14(6):515-24
pubmed: 23001745
BMJ. 2013 Jan 07;346:e8539
pubmed: 23295181
Nat Med. 2013 May;19(5):576-85
pubmed: 23563705
Ann Intern Med. 2014 Mar 18;160(6):398-406
pubmed: 24723079
Br J Nutr. 2014 Sep 14;112(5):762-75
pubmed: 24932617
Eur J Epidemiol. 2015 Jan;30(1):57-70
pubmed: 25377533
Asia Pac J Clin Nutr. 2015;24(1):90-100
pubmed: 25740747
Lancet Oncol. 2015 Dec;16(16):1599-600
pubmed: 26514947
J Hypertens. 2016 Sep;34(9):1721-9
pubmed: 27379533
JAMA Intern Med. 2016 Oct 1;176(10):1453-1463
pubmed: 27479196
Eur J Nutr. 2017 Dec;56(8):2565-2575
pubmed: 27517544
Eur Heart J. 2016 Nov 7;37(42):3232-3245
pubmed: 27523477
Nutr Res Rev. 2016 Dec;29(2):249-267
pubmed: 27666526
Eur J Clin Nutr. 2017 May;71(5):573-579
pubmed: 27804959
Eur J Clin Nutr. 2018 Jan;72(1):44-56
pubmed: 28952608
Eur J Epidemiol. 2018 Feb;33(2):137-140
pubmed: 29478107
Heart. 2018 Nov;104(21):1756-1763
pubmed: 29785957
Lancet. 2018 Nov 24;392(10161):2288-2297
pubmed: 30217460
BMJ. 1997 Jan 11;314(7074):112-7
pubmed: 9006469